BCL6 and lymphoma: Further, BCL6 expression has been shown to be unrestrained in some lymphomas, and it has been proposed that this mediates downregulation of PRDM1 and consequent cancer progression due to a dysregulated Blimp1-BCL6 axis (26, 87).